
Duval/CIBMTR Score for Acute Myelogenous Leukemia Survival
Estimates 3-year survival group for active AML patients undergoing haematopoietic cell transplantation


Estimates 3-year survival group for active AML patients undergoing haematopoietic cell transplantation
